Times are displayed in (UTC-05:00) Central Time (US & Canada) Change
5/4/2024 | 3:15 PM – 4:30 PM | Exhibit Hall F1
Poster Session—Mechanisms Associated with Immune Suppression and Polarization of Tumor-associated Myeloid Cells: Myeloid Cells, MDSC, Dendritic Cells and Macrophages in the Tumor Microenvironment (PM)
Microbiome-derived extracellular vesicles regulate neutrophil differentiation into myeloid-derived suppressor cells in cancer microenvironments.
(P110)Presentation Time: 03:15 PM–04:30 PM
Posterboard Number: 110
Abstract ID: 5705
Presenting Author:
Lily Mussallem, Univ. of Rochester Sch. of Med. & Dent.
Co-Authors:
Ankit Dahal, Univ. of Rochester Sch. of Med. & Dent.; Zahra Mahamed, Univ. of Rochester Sch. of Med. & Dent.; Minsoo Kim, Univ. of Rochester Sch. of Med. & Dent.;
View Abstract Details
Exportin 1 (XPO1) blockade regulates immunosuppressive function of tumor myeloid derived suppressor cells
(P114)Presentation Time: 03:15 PM–04:30 PM
Posterboard Number: 114
Abstract ID: 4294
Presenting Author:
Saeed Daneshmandi, Roswell Park Comp. Cancer Ctr.
Co-Authors:
Qi Yan, Roswell Park Comp. Cancer Ctr.; Jee Eun Choi, Roswell Park Comp. Cancer Ctr.; Eriko Katsuta, Yokohama City Univ.; Cameron R MacDonald, Roswell Park Comp. Cancer Ctr.; Mounika Goruganthu, Roswell Park Comp. Cancer Ctr.; Nathan Roberts, Roswell Park Comp. Cancer Ctr.; Elizabeth A Repasky, Roswell Park Comp. Cancer Ctr.; Prashant Singh, Roswell Park Comp. Cancer Ctr.; Kristopher Attwood, Roswell Park Comp. Cancer Ctr.; Jianmin Wang, Roswell Park Comp. Cancer Ctr.; Yosef Landesman, Karyopharm Therapeutics; Philip L McCarthy, Roswell Park Comp. Cancer Ctr.; Hemn Mohammadpour, Roswell Park Comp. Cancer Ctr.;
View Abstract Details
Inflammasome activation in macrophages limits CD8+ T cell response to radiotherapy
(P102)Presentation Time: 03:15 PM–04:30 PM
Posterboard Number: 102
Abstract ID: 5776
Presenting Author:
Sina Ramin, Earle A. Chiles Res. Inst., Providence Cancer Inst.
Co-Authors:
Marka R. Crittenden, Earle A. Chiles Res. Inst., Providence Cancer Inst.; Michael J. Gough, Earle A. Chiles Res. Inst., Providence Cancer Inst.; Terry R. Medler, Earle A. Chiles Res. Inst., Providence Cancer Inst.;
View Abstract Details
IL-8 Reprograms Monocyte-derived Macrophages into M2-like States in Human Glioblastoma
(P108)Presentation Time: 03:15 PM–04:30 PM
Posterboard Number: 108
Abstract ID: 4943
Presenting Author:
Stephanie Medina, Vanderbilt Univ.
Co-Authors:
Madeline J Hayes, Vanderbilt Univ.; Asa A Brockman, Vanderbilt Univ.; Rebecca A Ihrie, Vanderbilt Univ.; Jonathan m Irish, Vanderbilt Univ.;
View Abstract Details
Nerve- and Airway-Associated Interstitial Macrophages Regulate Anti-Tumor CD8 T Cell Immunity in Tumors in the Lung
(P100)Presentation Time: 03:15 PM–04:30 PM
Posterboard Number: 100
Abstract ID: 6121
Presenting Author:
Eric Bartnicki, NYU Grossman Sch. of Med.
Co-Authors:
Stephen T Yeung, NYU Grossman Sch. of Med.; Payal Damani-Yokota; Kamal K Khanna, NYU Grossman Sch. of Med.;
View Abstract Details
An insight into the role of myeloid/erythroid progenitors in tumor progression
(P116)Presentation Time: 03:15 PM–04:30 PM
Posterboard Number: 116
Abstract ID: 5844
Presenting Author:
Amirhossein Rahmati, Univ. of Alberta
Co-Author:
Shokrollah Elahi, Univ. of Alberta;
View Abstract Details
Liver metastases reprogram neutrophils to potentiate cancer progression
(P112)Presentation Time: 03:15 PM–04:30 PM
Posterboard Number: 112
Abstract ID: 4431
Presenting Author:
Ashley N Pearson, Univ. of Michigan Med. Sch.
Co-Authors:
Erin A Holcomb, Univ. of Michigan Med. Sch.; Jadyn James, Univ. of Michigan Med. Sch.; Zhuwen Wang, Univ. of Michigan Med. Sch.; Justine Kyi, Univ. of Michigan Med. Sch.; Amanda K Huber, Univ. of Michigan Med. Sch.; Michael D Green, Univ. of Michigan Med. Sch.;
View Abstract Details
The neuroblastoma anti-tumor immune response: macrophage modulation by amyloid precursor-like protein 2
(P106)Presentation Time: 03:15 PM–04:30 PM
Posterboard Number: 106
Abstract ID: 4351
Presenting Author:
Gabrielle L Brumfield, Univ. of Nebraska Med. Ctr., Buffett Cancer Ctr., Nebraska Med.
Co-Authors:
Alaina C Larson, Univ. of Nebraska Med. Ctr.; Shelby M Knoche, Univ. of Nebraska Med. Ctr.; Brittany J Poelaert, Univ. of Nebraska Med. Ctr.; Benjamin T Goetz, Univ. of Nebraska Med. Ctr.; Poomy Pandey, Univ. of Nebraska Med. Ctr.; Donald W Coulter, Univ. of Nebraska Med. Ctr.; Joyce C Solheim, Univ. of Nebraska Med. Ctr.;
View Abstract Details
The absence of macrophages migration inhibitory factor (MIF) reduces the number of tumors in colitits.associated colorectal cancer
(P104)Presentation Time: 03:15 PM–04:30 PM
Posterboard Number: 104
Abstract ID: 5670
Presenting Author:
Miriam Rodriguez-Sosa, Univ. Nacional Autónoma de México, Univ. Nacional Autónoma de México Fac. de Estudios Superiores Iztacala
Co-Authors:
Imelda Juarez Avelar, Univ. Nacional Autónoma de México Fac. de Estudios Superiores Iztacala; Ulises A. Andrade-Meza, Univ. Nacional Autónoma de México Fac. de Estudios Superiores Iztacala; Betsaida J. Ortiz Sánchez, Univ. Nacional Autónoma de México Fac. de Estudios Superiores Iztacala; Danae B. Mendoza Sánchez, Univ. Nacional Autónoma de México Fac. de Estudios Superiores Iztacala; D Alexia Sánchez Arteaga, Univ. Nacional Autónoma de México Fac. de Estudios Superiores Iztacala;
View Abstract Details
PD-L1 deletion on T cells results in a pro-tumorigenic environment
(P122)Presentation Time: 03:15 PM–04:30 PM
Posterboard Number: 122
Abstract ID: 5464
Presenting Author:
Konstantinos Aliazis, Beth Israel Deaconess Med. Ctr., Harvard Med. Sch.
Co-Authors:
Rushil Shah, Beth Israel Deaconess Med. Ctr., Harvard Med. Sch.; Sasitorn Yenyuwadee, Beth Israel Deaconess Med. Ctr., Harvard Med. Sch.; Rinku Pal, Beth Israel Deaconess Med. Ctr., Harvard Med. Sch.; Vassiliki A Boussiotis, Beth Israel Deaconess Med. Ctr., Harvard Med. Sch.;
View Abstract Details